Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

US Army says Congress doubled funds for 155 artillery

Published 05/02/2024, 05:53 PM
Updated 05/02/2024, 05:55 PM
GD
-

By Mike Stone

WASHINGTON (Reuters) - The U.S. Army said Congress doubled to $6 billion its funding request for buying and building 155 millimeter artillery rounds to replace stocks depleted by shipments to Ukraine and now Israel, an Army official said on Thursday.

Demand for 155 mm artillery rounds has soared since Russia invaded Ukraine in February 2022. Allies' supplies for their own defense have been run down as they have rushed shells to Kyiv, which fires thousands of rounds per day.

"By my math, the supplemental, we asked for about $3.1 billion related to 155 production and production increases. We appear to have gotten $6 billion. So that, I think, is a vote of confidence as we make our way to 100,000 shells a month." Doug Bush, the chief weapons buyer for the Army, said Tuesday

The U.S. Army included $3.1 billion to buy the artillery rounds and expand production in the recently signed $95 billion supplemental bill.

The U.S. plans to increase its monthly production rate for 155 millimeter artillery shells to 100,000 in the summer of 2025 Bush told reporters Thursday.

General Dynamics (NYSE:GD) benefits from Pentagon spending to replace equipment sent to Ukraine, including 155 millimeter artillery.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.